Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Medical imaging-based ‘virtual biopsies’ move closer to replacing traditional tissue techniques

The new approach relies on radiomic CT data combined with ultrasound imaging to create a visual guide for doctors, researchers explained in European Radiology.

Thumbnail

Hitachi inks five-year deal with Olympus to jointly develop endoscopic ultrasound systems

Officials said the pact will remain in place after Hitachi completes the sale of its imaging products to Fujifilm. 

Thumbnail

NorthStar’s recent FDA approval enables a fourfold increase in Mo-99 production

This marks the first and only commercial-scale application of concentrated molybdenum-98 technology, the Beloit, Wisconsin-based firm said recently.

Thumbnail

Interventional radiology community calls on WHO to enhance access to IR services across the globe

Specifically, the open letter urges the World Health Organization to address the IR care gap between low- and high-income countries.

Thumbnail

New copper PET tracer one-two punch identifies deadly tumors and boosts survival

“This offers the potential to provide diagnostic imaging using copper-64 to plan individualized treatments with copper-67 agents for a wide range of cancer patients," Australian researchers explained in the Journal of Nuclear Medicine.

COVID-19 patients with neurological problems requiring brain imaging face increased risk of death

Those who underwent neuroimaging and were diagnosed with stroke were also twice as likely to die compared to age-matched controls, according to new research published in Neurology.

Medical isotope firm Shine breaks ground on new 54,000-square-foot facility

By 2022, the company said its facility will be fully operational and capable of producing more than 300,000 doses of lutetium-177 each year.

Thumbnail

COVID-19 pushes lung cancer screening rates lower and sends malignancies up to 29%

Prior to the pandemic, the University of Cincinnati College of Medicine said its rate stood at about 8%, physicians reported on Thursday.